Reports to the vaccine adverse event reporting system after hepatitis a and hepatitis AB vaccines in pregnant women

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 6, 2014, Pages 561.e1-561.e6

  Moro, Pedro L ^a   Museru, Oidda I ^a   Niu, Manette ^b   Lewis, Paige ^a   Broder, Karen ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

hepatitis A hepatitis B combined vaccine; hepatitis A vaccine; pregnancy; surveillance; vaccine safety

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ABDOMINAL CRAMP; ADOLESCENT; ADULT; ALLERGIC REACTION; APNEA; ARTICLE; BIRTH DEFECT; DIZZINESS; DRUG SURVEILLANCE PROGRAM; ELECTIVE TERMINATION; EXTREMITY PAIN; FEMALE; FETUS DISTRESS; FIRST TRIMESTER PREGNANCY; FLATULENCE; GESTATIONAL AGE; HERPETIC STOMATITIS; HUMAN; HYDRAMNIOS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT DISEASE; INJECTION SITE PAIN; LARGE FOR GESTATIONAL AGE; LARYNGOTRACHEOMALACIA; LIP DISEASE; LUNG DISEASE; LUNG IMMATURITY; MAJOR CLINICAL STUDY; MEDICAL RECORD; NAUSEA AND VOMITING; NEWBORN JAUNDICE; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PALLOR; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PELVIC PAIN; PHOCOMELIA; PNEUMONIA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SINUSITIS; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; STRIDOR; URINARY TRACT INFECTION; UTERUS DISEASE; VACCINATION; VACCINATION REACTION; VACCINE ADVERSE EVENT REPORTING SYSTEM; VAGINA BLEEDING; WEIGHT REDUCTION;

HEPATITIS A HEPATITIS B COMBINED VACCINE; HEPATITIS A VACCINE; PREGNANCY; SURVEILLANCE; VACCINE SAFETY;

ABORTION, SPONTANEOUS; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; HEPATITIS A; HEPATITIS B; HUMANS; INFANT, NEWBORN; PREGNANCY; PREMATURE BIRTH; UNITED STATES; URINARY TRACT INFECTIONS; VIRAL HEPATITIS VACCINES;

EID: 84901609444     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.12.036     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 55 2006 1 23
2. Centers for Disease Control and Prevention Notice to readers: FDA approval for a combined hepatitis A and B vaccine MMWR 50 2001 806 807
3. A.T. Kroger, C.V. Sumaya, L.K. Pickering, W.L. Atkinson Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 60 2011 1 60 Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm?s-cid= rr6002a1-e Accessed July 19, 2013
4. E.A. Ayoola, and A.O. Johnson Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants Int J Gynaecol Obstet 25 1987 297 301
5. M. Levy, and G. Koren Hepatitis B vaccine in pregnancy: maternal and fetal safety Am J Perinatol 8 1991 227 232
6. J.S. Sheffield, A. Hickman, and J. Tang et al. Efficacy of an accelerated hepatitis B vaccination program during pregnancy Obstet Gynecol 117 2011 1130 1135
7. GlaxoSmithKline Pregnancy Registries. Twinrix pregnancy registry for twinrix hepatitis A and hepatitis B (recombinant) vaccine. Available at: http://pregnancyregistry.gsk.com/twinrix.html. Accessed July 19, 2013.
8. J.A. Singleton, J.C. Lloyd, G.T. Mootrey, M.E. Salive, and R.T. Chen An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group Vaccine 17 1999 2908 2917
9. F. Varricchio, J. Iskander, and F. DeStefano Understanding vaccine safety information from the Vaccine Adverse Event Reporting System Pediatr Infect Dis J 2004 287 294
10. R.T. Chen, S.C. Rastogi, and J.R. Mullen et al. The Vaccine Adverse Event Reporting System (VAERS) Vaccine 12 1994 542 550
11. U.S. Department of Health and Human Services. VAERS table of reportable events following vaccination. Available at: http://vaers.hhs.gov/resources/ VAERS-Table-of-Reportable-Events-Following-Vaccination.pdf. Accessed Nov. 19, 2013.
12. U.S. Department of Health and Human Services. Vaccine Adverse Event Reporting System form. Available at: http://vaers.hhs.gov/resources/vaers-form. pdf. Accessed July 19, 2013.
13. Medical dictionary for regulatory activities maintenance and support services organization. MedDRA; McLean, VA: 2010. Available at: http://www.meddra.org/. Accessed July 19, 2013.
14. Food and Drug Administration. 21 Code of Federal Regulation Part 600.80. Postmarketing reporting of adverse experiences. 1997;62:Federal Register: 52252-53. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=600.80. Accessed July 19, 2013.
15. Prenatal care G. Cunningham, K.J. Leveno, S.L. Bloom, J.C. Hauth, D.J. Rouse, and C.Y. Spong Williams' obstetrics 23rd ed. 2010 McGraw-Hill New York 189 214
16. S.J.W. Evans, P.C. Waller, and S. Davis Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports Pharmacoepid Drug Safety 10 2001 483 486
17. D. Banks, E.J. Woo, D.R. Burwen, P. Perucci, M.M. Braun, and R. Ball Comparing data mining methods on the VAERS database Pharmacoepid Drug Saf 14 2005 601 609
18. P.L. Moro, K. Broder, and Y. Zheteyeva et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009 Am J Obstet Gynecol 204 2011 146.e1 146.e7
19. P.L. Moro, K. Broder, and Y. Zheteyeva et al. Adverse events in pregnant women following administration of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System (VAERS) Am J Obstet Gynecol 205 2011 473.e1 473.e9
20. J.G. Wright, C.P. Quinn, S. Shadomy, N. Messonnier Centers for Disease Control and Prevention (CDC) Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009 MMWR Recommit Rep 59 2010 1 30
21. S. Black, J. Eskola, and C.A. Siegrist et al. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines Lancet 374 2009 2115 2122
22. Y.A. Zheteyeva, P.L. Moro, and N.K. Tepper et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women Am J Obstet Gynecol 207 2012 59.e1 59.e7
23. S. Wacholder, B.E. Chen, and A. Wilcox et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials BMJ 340 2010 c712
24. M.F. MacDorman, S.E. Kimeyer, and E.C. Wilson Fetal and perinatal mortality, United States, 2006 Natl Vital Stat Rep 60 2012 1 23 Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60-08.pdf Accessed July 19, 2013
25. J.A. Martin, B.E. Hamilton, and S.J. Ventura et al. Births: final data for 2010 Natl Vital Stat Rep 61 2012 1 100 Available at: http://www.cdc.gov/ nchs/data/nvsr/nvsr61/nvsr61-01.pdf Accessed Aug. 9, 2013
26. J.C. Vazquez, and E. Abalos Treatments for symptomatic urinary tract infections during pregnancy Cochrane Database Syst Rev 2011 CD002256
27. E. Bermejo-Sánchez, L. Cuevas, and E. Amar et al. Amelia: a multi-center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature Am J Med Genet C Semin Med Genet 157C 2011 288 304
28. A. Correa, J.D. Cragan, and J.E. Kucik et al. Reporting birth defects surveillance data 1968-2003 Birth Defects Res A Clin Mol Teratol 79 2007 65 186